Wearable Devices Ltd. ( ($WLDS) ) has provided an update. On January 30, 2025, Wearable Devices Ltd. announced the successful closing of a $2.5 ...
Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...